Peanut patch could let allergic kids tolerate small amounts of peanut

NCT ID NCT05741476

Ongoing Disease control Sponsor: DBV Technologies Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a daily skin patch called DBV712 (Viaskin Peanut) in 600 children aged 4-7 with peanut allergy. The patch delivers a tiny amount of peanut protein to train the immune system to be less sensitive. After 12 months, researchers check if children can safely eat more peanut than before without a reaction. The goal is to reduce the risk of severe reactions from accidental peanut exposure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DBV712 (Viaskin Peanut) – a skin patch that delivers a small amount of peanut protein to help the immune system get used to it
What this could lead to: If it works, this patch could allow children with peanut allergy to safely eat small amounts of peanut without a severe reaction, reducing the risk from accidental exposure.
What could go wrong: This is a phase 3 trial, but results are not yet final. The patch may not work for all children, and some may still have allergic reactions. Side effects like skin irritation or, rarely, severe allergic reactions are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

food allergy Nut and Peanut Hypersensitivity Peanut Hypersensitivity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALLERGY, PEANUT

Contacts and locations

Show contact details

Locations

DBV Investigative Site

Birmingham, Alabama, 35233, United States
DBV Investigative Site

Tucson, Arizona, 85724, United States
DBV Investigative Site

Little Rock, Arkansas, 72202, United States
DBV Investigative Site

Los Angeles, California, 90027, United States
DBV Investigative Site

Los Angeles, California, 90095, United States
DBV Investigative Site

San Diego, California, 92123, United States
DBV Investigative Site

San Francisco, California, 94158, United States
DBV Investigative Site

San Jose, California, 95117, United States
DBV Investigative Site

Aurora, Colorado, 80045, United States
DBV Investigative Site

Colorado Springs, Colorado, 80907, United States
DBV Investigative Site

Washington D.C., District of Columbia, 20010, United States
DBV Investigative Site

Hollywood, Florida, 33021, United States
DBV Investigative Site

Miami, Florida, 33136, United States
DBV Investigative Site

St. Petersburg, Florida, 33701, United States
DBV Investigative Site

Tampa, Florida, 33613, United States
DBV Investigative Site

Marietta, Georgia, 30060, United States
DBV Investigative Site

Chicago, Illinois, 60611, United States
DBV Investigative Site

Normal, Illinois, 61761, United States
DBV Investigative Site

Indianapolis, Indiana, 46202, United States
DBV Investigative Site

Louisville, Kentucky, 40215, United States
DBV Investigative Site

Baltimore, Maryland, 21287, United States
DBV Investigative Site

Chevy Chase, Maryland, 20815, United States
DBV Investigative Site

Boston, Massachusetts, 02114, United States
DBV Investigative Site

Boston, Massachusetts, 02115, United States
DBV Investigative Site

Taunton, Massachusetts, 02780, United States
DBV Investigative Site

Ann Arbor, Michigan, 48106, United States
DBV Investigative Site

Ypsilanti, Michigan, 48197, United States
DBV Investigative Site

Maplewood, Minnesota, 55109, United States
DBV Investigative Site

Kansas City, Missouri, 64108, United States
DBV Investigative Site

Great Neck, New York, 11021, United States
DBV Investigative Site

New York, New York, 10016, United States
DBV Investigative Site

New York, New York, 10029, United States
DBV Investigative Site

Rochester, New York, 14642, United States
DBV Investigative Site

Chapel Hill, North Carolina, 27599, United States
DBV Investigative Site

Cincinnati, Ohio, 45229, United States
DBV Investigative Site

Cleveland, Ohio, 44106, United States
DBV Investigative Site

Cleveland, Ohio, 44195, United States
DBV Investigative Site

Columbus, Ohio, 43205, United States
DBV Investigative Site

Philadelphia, Pennsylvania, 19104, United States
DBV Investigative Site

Pittsburgh, Pennsylvania, 15224, United States
DBV Investigative Site

Memphis, Tennessee, 38105, United States
DBV Investigative Site

Nashville, Tennessee, 37232, United States
DBV Investigative Site

Austin, Texas, 78723, United States
DBV Investigative Site

Dallas, Texas, 75235, United States
DBV Investigative Site

Houston, Texas, 77030, United States
DBV Investigative Site

Seattle, Washington, 98101, United States
DBV Investigative Site

Seattle, Washington, 98115, United States
DBV Investigative Site

Milwaukee, Wisconsin, 53226, United States
DBV Investigative Site

Adelaide, 5006, Australia
DBV Investigative Site

Nedlands, 6009, Australia
DBV Investigative Site

Parkville, 3052, Australia
DBV Investigative Site

Richmond, 3121, Australia
DBV Investigative Site

South Brisbane, 4101, Australia
DBV Investigative Site

Westmead, 2145, Australia
DBV Investigative Site

Vancouver, British Columbia, V6H 3V4, Canada
DBV Investigative Site

Winnipeg, Manitoba, R3J 0S9, Canada
DBV Investigative Site

Burlington, Ontario, L7L6W6, Canada
DBV Investigative Site

North York, Ontario, M3B3S6, Canada
DBV Investigative Site

Ottawa, Ontario, M5G 1X8, Canada
DBV Investigative Site

Toronto, Ontario, K1H1E4, Canada
DBV Investigative Site

Montreal, Quebec, H3T 1C5, Canada
DBV Investigative Site

Montreal, Quebec, H4A3J1, Canada
DBV Investigative Site

Québec, Quebec, G1v4W2, Canada
DBV Investigative Site

Hamilton, L8SIG5, Canada
DBV Investigative Site

Angers, 49933, France
DBV Investigative Site

Brest, 29609, France
DBV Investigative Site

Bron, 69500, France
DBV Investigative Site

Nice, 06200, France
DBV Investigative Site

Strasbourg, 67091, France
DBV Investigative Site

Vandœuvre-lès-Nancy, 54511, France
DBV Investigative Site

Düsseldorf, 40217, Germany
DBV Investigative Site

Frankfurt, 60590, Germany
DBV Investigative Site

Ulm, 89075, Germany
DBV Investigative Site

Cork, T12 DC4A, Ireland
DBV Investigative Site

Dublin, D12N512, Ireland
DBV Investigative Site

Rotterdam, 3015 CN, Netherlands
DBV Investigative Site

Utrecht, 3584 EA, Netherlands
DBV Investigative Site

Madrid, 28009, Spain
DBV Investigative Site

Madrid, 28034, Spain
DBV Investigative Site

Málaga, CP 29011, Spain
DBV Investigative Site

London, SE1 7ETH, United Kingdom
DBV Investigative Site

London, W2 1NY, United Kingdom
DBV Investigative Site

Manchester, M13 9WL, United Kingdom
DBV Investigative Site

Sheffield, S10 2TH, United Kingdom
DBV Investigative Site

Southampton, SO16 6YD, United Kingdom
DBV Investigative site

Mission Viejo, California, 92691, United States
DBV Investigative site

Atlanta, Georgia, 30329, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Peanut allergy pill shows promise in early trial